skip to primary navigationskip to content
 

Responsive Polymer Chemistry

Mark Cambridge UK, April 9, 2003, Vivamer Ltd announces that it has secured seed finance from the University of Cambridge Challenge Fund. Professor Nigel Slater and Dr Mark Eccleston (pictured left) of the Department of Chemical Engineering, University of Cambridge, founded Vivamer to commercialise their responsive polymer chemistry. The seed financing will be used to demonstrate the utility of Vivamer's technology in the areas of diagnostic imaging and drug delivery for anti-cancer applications.

Responsive polymers react to their environment and can be designed to act as a molecular switch turning on or off chemical properties associated with payload compounds. For example, in response to a change in pH at a site of disease, a Vivamer polymer could release a drug payload, delivering the drug directly to the site of disease. The technology has numerous applications including healthcare, household chemicals and food technology.

"Responsive polymers offer a number of compelling benefits in healthcare applications," said Professor Slater. "By releasing drugs or activating imaging agents in response to the disease environment you have greater control over the patient’s treatment".

Bill Mathews commented, "Vivamer is the latest company to emerge from Cambridge University, and demonstrates the university’s continuing expertise in commercializing world class inventions. We believe that Vivamer's chemistry platform has the potential to deliver significant value to its commercial partners across a range of industries".

Vivamer was founded in December 2002 to commercialise responsive polymer chemistry developed by Professor Nigel Slater and Mark Eccleston. Professor Slater's work at Cambridge focuses on Bio-products manufacturing and functional, bio-mimetic materials and his work is related to the Bioscience engineering research theme.

The University of Cambridge Challenge Fund provides seed finance to companies spun out of the University of Cambridge. It has made investments in 11 companies including Daniolabs, Akubio and Cambridge Semiconductor since it was set up in 2000.

RSS Feed Latest news

Dr Janire Saez awarded Marie Curie Fellowship

Jun 14, 2019

Dr Janire Saez awarded Marie Curie Fellowship for her work on organ-on-chip devices for cancer research.

Senior academic promotions in the department

Jun 13, 2019

Dr Bart Hallmark has been promoted to University Senior Lecturer, and Dr Ljiljana Fruk and Dr Andy Sederman both promoted to Personal Readerships.

Design Project winners 2019

Jun 10, 2019

Congratulations to the two winning groups of our 2019 Design Project on "the processing of sour North Sea gas".

View all news

Upcoming events

CAS Consultancy talk: Assembly Effect with Troika

Jun 19, 2019

Department of Chemical Engineering & Biotechnology (Atrium) Philippa Fawcett Drive Cambridge, CB3 0AS

CEB Research Conference 2019

Jun 25, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Africans in STEM Symposium

Jun 28, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Machine learning and AI in (bio)chemical engineering

Jul 08, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Upcoming events